Identifying a Six-Gene Signature Predicting Response to TACE in Hepatocellular Carcinoma by Bioinformatics Analysis
Background and Aim. With regard to patients with intermediate-stage, irresectable hepatocellular carcinoma (HCC), transcatheter arterial chemoembolization (TACE) is the mainstay of treatment. There is an urgent clinical requirement to identify reliable biomarkers to predict the response of HCC patie...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | Journal of Nanomaterials |
Online Access: | http://dx.doi.org/10.1155/2021/3249816 |